Skip To Main Content

Science at Sanofi

Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content
Management of ASMD - Expert opinion: Professor Tawfeq Ben Omran

Management of ASMD - Expert opinion: Professor Tawfeq Ben Omran

Professor Tawfeq explains the benefits of the ERT Olipudase Alfa on patients diagnosed with ASMD.

Management of ASMD - Expert opinion: Professor Moeen Al Sayed

Management of ASMD - Expert opinion: Professor Moeen Al Sayed

Professor Moeen gives a detailed explanation on how Olipudase Alfa acts in the body once administered.

Navigating the Pompe Disease Journey

Navigating the Pompe Disease Journey

Recognizing Key Signs and Symptoms Along the Way

Acquired Thrombotic Thrombocytopenic Purpura (aTTP)

Acquired Thrombotic Thrombocytopenic Purpura (aTTP)

ISTH Guidelines

ISTH Guidelines

Differential Diagnostics for ASMD in Patients Suspected to have GD

Differential Diagnostics for ASMD in Patients Suspected to have GD

Prospective evaluation of lipid management following ACS in Saudi Arabia (ACOSYM Study)

Prospective evaluation of lipid management following ACS in Saudi Arabia (ACOSYM Study)

Acute LDL-C Reduction Post ACS: Strike Early and Strike Strong: From Evidence to Clinical Practice

Acute LDL-C Reduction Post ACS: Strike Early and Strike Strong: From Evidence to Clinical Practice

PN Expert Interview Series with Dr. Shawn Kwatra

PN Expert Interview Series with Dr. Shawn Kwatra

Impact of symptoms and risk of ASMD on patients and caregivers

Impact of symptoms and risk of ASMD on patients and caregivers

Consensus Guidelines for the Clinical Management of ASMD

Consensus Guidelines for the Clinical Management of ASMD

Glargine 300 use in people with type 2 diabetes who fast during Ramadan

Glargine 300 use in people with type 2 diabetes who fast during Ramadan